Evidence map›Paper›PMID 29296123›Full record

ArticleDiabetology & metabolic syndrome2017

Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years.

Andréa Cristina Sousa, Thiago Veiga Jardim, Thiago Olivera Costa, Fabrício Galdino Magalhães, Marcos Paulo Marinho Montelo, Weimar K Barroso Souza, Paulo César Brandão Veiga Jardim, Ana Luiza Lima Sousa

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Andréa Cristina SousaHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Thiago Veiga JardimHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Thiago Olivera CostaHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Fabrício Galdino MagalhãesHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Marcos Paulo Marinho MonteloHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Weimar K Barroso SouzaHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Paulo César Brandão Veiga JardimHypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Ana Luiza Lima SousaNursing School, Federal University of Goiás (Universidade Federal de Goiás), Goiânia, Brazil.
Universidade Federal de Goiás · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetics have increased risks for cardiovascular disease (CVD) and mortality, reducing their life expectancy by up to 15 years. Type 2 diabetes mellitus specifically increases the risk for cardiovascular mortality nearly fivefold. When hypertension is combined with diabetes, the risk of CVD is even greater.

objectiveIdentify non-fatal cardiovascular outcomes and renal function impairment in a cohort of hypertensive patients in regular treatment in a reference treatment center, over 11 years of follow-up.

methodsHistorical cohort of hypertensive patients in regular treatment for at least 11 years in a specialized service for hypertension treatment. The exposed group was hypertensive diabetic patients at the beginning of the cohort, and the non-exposed group had hypertension without diabetes. The cohort began in 2004, with follow-ups in 2009 and 2015. Variables used: gender, race, age, physical activity, alcohol consumption, smoking, blood pressure, body mass index, glycated hemoglobin, diabetes and hypertension diagnosis times, treatment time in specialized service, non-fatal cardiovascular outcomes, and renal impairment assessed by creatinine clearance.

results139 patients participated in the study (55 diabetic hypertensive; 84 non-diabetic hypertensive), with an initial (2004) mean hypertension treatment time of 5.8 years. Females were the majority (75.5%) in both groups. Groups were similar regarding socio-demographic variables, but the group of hypertensive diabetic patients had higher frequency of obesity and uncontrolled BP, which persisted in all follow-ups. In 11 years of follow-up (2004-2015), the diabetic group had more cardiovascular events, with increased risk of acute myocardial infarction (RR 95% CI 1.6 12.2-95.0), stroke (RR 95% CI 1.3-6.1 27.7) and complications requiring hospitalization (RR 95% CI 1.6 2.2-3.0). Worsened renal function occurred more often in the non-exposed group, but in the end, the proportion of renal function loss was similar between groups.

conclusionsExposure to type 2 diabetes increased the risk of new cardiovascular outcomes over 11 years of follow-up of hypertensive patients. Diabetes by itself increased the risk of cardiovascular outcomes, justifying more intensive actions in this population.

Indexed as

Cardiovascular diseasesDiabetes complicationHypertensionType 2 diabetes mellitus

Identifiers

PMID29296123
PMCPMC5738831
OpenAlexW2775619328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.